Skip to main content
    H

    Hims Hers Health Inc (HIMS)

    Official site

    HEALTHCARE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $17.55
    -1.01 (-5.44%)

    Market Cap: $4.62B

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Hims Hers Health Inc (HIMS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Hims Hers Health (HIMS) has a market cap of $4.62B and an enterprise value of $5.39B. Revenue grew 29.79% over the last 12 months from the 12 months before. Its share count is up 3.30% from a year earlier.

    Total Valuation

    Enterprise value is 16.47% above the market cap, as debt exceeds cash.

    Market Cap$4.62B
    Enterprise Value$5.39B
    Latest price (Nov 17, 2026)$17.55

    Key Dates

    The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 22, 2027 (expected)
    Last Earnings DateNov 9, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.90% in the quarter ended Sep 30, 2026 and grew 3.90% a year over 2 years.

    Shares Outstanding233.82M
    Shares Change (YoY)+3.30%
    Shares Change (QoQ)+0.90%
    Share Count Growth (2Y CAGR)+3.90%

    Valuation Ratios

    Sales and book value multiples are 1.4x and 11.5x. Its year-end P/S ranged from 2.1x to 4.5x from 2021 to 2025.

    P/S Ratio1.4x
    Forward P/S1.5x
    P/B Ratio11.5x
    P/FCF Ratio497.8x
    P/OCF Ratio25.7x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 590.2x free cash flow.

    EV / Sales1.9x
    EV / FCF590.2x

    Price Statistics

    The stock is down 52.54% over 52 weeks and trades 35.50% below its 50-day average.

    Beta (1Y)2.63
    52-Week Change-52.54%
    1-Month Change-37.66%
    3-Month Change-43.55%
    6-Month Change-21.79%
    5-Year Change+254.87%
    Total Return (1Y)-52.54%
    Total Return (3Y CAGR)+32.93%
    Total Return (5Y CAGR)+18.83%
    Return vs SPY (1Y)-63.16%
    Max Drawdown (1Y)-63.72%
    Max Drawdown (3Y)-78.88%
    Sharpe Ratio (1Y)-0.80
    Correlation with SPY (1Y)0.40
    50-Day Average$27.21
    200-Day Average$26.59
    52-Week Range$13.74 to $40.99
    RSI (14 Days)29.5
    Average Volume (20 Days)15.52M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.92x current liabilities, and total debt is 3.85x shareholder equity.

    Current Ratio0.92x
    Quick Ratio0.84x
    Debt / Equity3.85x
    Debt / FCF165.87x

    Returns and Efficiency

    Return on invested capital is -11.07% over the last 12 months, against a 5-year average of -6.50%.

    Return on Equity (ROE)-53.71%
    Return on Assets (ROA)-5.38%
    Return on Invested Capital (ROIC)-11.07%
    Return on Capital Employed (ROCE)-10.51%
    ROE (5Y Average)-1.98%
    ROA (5Y Average)-5.02%
    ROIC (5Y Average)-6.50%
    Asset Turnover0.99x
    Inventory Turnover10.61x
    Receivables Turnover7.15x
    Cash Conversion Cycle-93 days

    Scores

    HIMS has an Altman Z-Score of 1.21, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score1.21
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $2.87B over the last 12 months.

    Revenue$2.87B
    Revenue Growth (YoY)+29.79%
    Gross Profit$1.83B
    Operating Income-$232.47M
    Pretax Income-$222.08M
    Net Income-$190.84M
    EBITDA-$107.35M
    EBIT-$221.90M
    Reported EPS (TTM)-$0.39

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 10.01% of the $3.55B in total assets.

    Cash and Equivalents$605.60M
    Total Debt$1.37B
    Net Debt$761.79M
    Net Debt Per Share$3.26
    Working Capital-$114.84M
    Shareholder Equity$355.30M
    Book Value Per Share$1.52
    Tangible Book Value-$1.15B
    Total Assets$3.55B
    Total Liabilities$3.19B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $171.88M of capital spending, operating cash flow left $8.24M of free cash flow.

    Operating Cash Flow$180.12M
    Capital Expenditures$171.88M
    Free Cash Flow$8.24M
    FCF Per Share$0.04
    Depreciation and Amortization$114.55M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -8.10%, against a 5-year average of -10.01%.

    Gross Margin63.82%
    Operating Margin-8.10%
    Pretax Margin-7.74%
    Net Margin-6.65%
    EBITDA Margin-3.74%
    EBIT Margin-7.73%
    FCF Margin0.29%
    Gross Margin (5Y Average)77.61%
    Operating Margin (5Y Average)-10.01%
    Net Margin (5Y Average)-8.15%

    Growth

    Revenue grew 64.55% a year over 3 years.

    Revenue Growth (3Y CAGR)+64.55%
    Revenue Growth (5Y CAGR)+73.63%
    Book Value Per Share Growth (2Y CAGR)+15.29%
    Tangible Book Per Share Growth (2Y CAGR)-48.82%

    Revenue and profit by year

    Dividends and Yields

    HIMS does not pay a dividend. Its free cash flow yield is 0.20%.

    FCF Yield0.20%
    Buyback Yield1.88%
    Shareholder Yield1.88%

    Peer Position

    Against 12 similar companies, HIMS has the 10th highest P/S.

    P/S Ratio1.4x vs 3.0x median
    ROIC-11.07% vs 11.58% median
    Revenue Growth (Trailing 4 Quarters, YoY)+29.79% vs +10.45% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 28.22% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+28.22%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About HIMS

    What is HIMS's market cap?

    Hims Hers Health has a market cap of $4.62B. Its enterprise value, which adds debt and subtracts cash, is $5.39B.

    How many shares of HIMS are outstanding?

    Hims Hers Health has 233.82M shares outstanding. The count is up 3.30% from a year earlier.

    Does HIMS pay a dividend?

    No. Hims Hers Health does not pay a dividend.

    How much debt does HIMS have?

    Hims Hers Health has $1.37B of total debt and $605.60M of cash and equivalents, a net debt position of $761.79M.